Kotak funds provide acquisition financing to Matrix Pharma

Kotak Investment Advisor, via Kotak Strategic Situations India Fund II and Kotak Alternate Asset Managers Limited will subscribe to optionally convertible debentures of Matrix Pharma Pvt Ltd.Matrix Pharma will use the proceeds of OCDs towards acquisition of Tianish Laboratories, a Hyderabad-based active pharmaceutical ingredients (API) maker.